<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK396098" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK396098/" /><meta name="ncbi_pagename" content="MPPH Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>MPPH Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="MPPH Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/11/17" /><meta name="citation_author" content="Ghayda Mirzaa" /><meta name="citation_pmid" content="27854409" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK396098/" /><meta name="citation_keywords" content="Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome" /><meta name="citation_keywords" content="Megalencephaly-Postaxial Polydactyly-Polymicrogyria-Hydrocephalus Syndrome" /><meta name="citation_keywords" content="Megalencephaly-Postaxial Polydactyly-Polymicrogyria-Hydrocephalus Syndrome" /><meta name="citation_keywords" content="Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome" /><meta name="citation_keywords" content="G1/S-specific cyclin-D2" /><meta name="citation_keywords" content="Phosphatidylinositol 3-kinase regulatory subunit beta" /><meta name="citation_keywords" content="RAC-gamma serine/threonine-protein kinase" /><meta name="citation_keywords" content="AKT3" /><meta name="citation_keywords" content="CCND2" /><meta name="citation_keywords" content="PIK3R2" /><meta name="citation_keywords" content="MPPH Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="MPPH Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Ghayda Mirzaa" /><meta name="DC.Date" content="2016/11/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK396098/" /><meta name="description" content="The MPPH syndrome is a developmental brain disorder characterized by megalencephaly (brain overgrowth) with the cortical malformation bilateral perisylvian polymicrogyria (BPP). At birth the occipital frontal circumference (OFC) ranges from normal to 6 standard deviations (SD) above the mean for age, sex, and gestational age; in older individuals the range is from 3 to 10 SD above the mean. A variable degree of ventriculomegaly is seen in almost all children with MPPH syndrome; nearly 50% of those have frank hydrocephalus. Neurologic problems associated with BPP include oromotor dysfunction (100%), epilepsy (50%), and mild to severe intellectual disability (100%). Postaxial hexadactyly occurs in 50% of individuals with MPPH syndrome." /><meta name="og:title" content="MPPH Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="The MPPH syndrome is a developmental brain disorder characterized by megalencephaly (brain overgrowth) with the cortical malformation bilateral perisylvian polymicrogyria (BPP). At birth the occipital frontal circumference (OFC) ranges from normal to 6 standard deviations (SD) above the mean for age, sex, and gestational age; in older individuals the range is from 3 to 10 SD above the mean. A variable degree of ventriculomegaly is seen in almost all children with MPPH syndrome; nearly 50% of those have frank hydrocephalus. Neurologic problems associated with BPP include oromotor dysfunction (100%), epilepsy (50%), and mild to severe intellectual disability (100%). Postaxial hexadactyly occurs in 50% of individuals with MPPH syndrome." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK396098/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/mpph/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK396098/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BB837E04144210000000001F200AA.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK396098_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK396098_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/merrf/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mpv17-mtdep/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK396098_"><span class="title" itemprop="name">MPPH Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome, Megalencephaly-Postaxial Polydactyly-Polymicrogyria-Hydrocephalus Syndrome</div><p class="contrib-group"><span itemprop="author">Ghayda Mirzaa</span>, MD, FAAP, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK396098_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK396098_ai__"><div class="contrib half_rhythm"><span itemprop="author">Ghayda Mirzaa</span>, MD, FAAP, FACMG<div class="affiliation small">Seattle Children's Research Institute<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@aazrimg" class="oemail">ude.wu@aazrimg</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 17, 2016</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="mpph.Summary" itemprop="description"><h2 id="_mpph_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The MPPH syndrome is a developmental brain disorder characterized by megalencephaly (brain overgrowth) with the cortical malformation bilateral perisylvian polymicrogyria (BPP). At birth the occipital frontal circumference (OFC) ranges from normal to 6 standard deviations (SD) above the mean for age, sex, and gestational age; in older individuals the range is from 3 to 10 SD above the mean. A variable degree of ventriculomegaly is seen in almost all children with MPPH syndrome; nearly 50% of those have frank hydrocephalus. Neurologic problems associated with BPP include oromotor dysfunction (100%), epilepsy (50%), and mild to severe intellectual disability (100%). Postaxial hexadactyly occurs in 50% of individuals with MPPH syndrome.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The clinical diagnosis of MPPH syndrome can be established in individuals with the two core features: megalencephaly and BPP. The molecular diagnosis of MPPH syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with some of the suggestive clinical and imaging features and the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of three genes: <i>AKT3</i>, <i>CCND2</i>, or <i>PIK3R2</i>. While most individuals with MPPH syndrome have a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variant in one of these three genes, some have a somatic mosaic pathogenic variant (most commonly reported in <i>PIK3R2</i>).</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Hydrocephalus warrants early neurosurgical intervention. Oromotor difficulties, developmental delays, and epilepsy are treated as per usual clinical care standards.</p><p><i>Surveillance:</i> Follow up with a pediatric neurologist, at least every six months until age six years, and yearly thereafter. Brain MRI to detect hydrocephalus and/or cerebellar tonsillar ectopia is provisionally recommended every six months from birth to age two years, and yearly from age two to six years. In older individuals, the frequency should be determined within the context of prior brain imaging findings and clinical findings. Long-term neurologic follow up is warranted for epilepsy. Routine follow up with a developmental pediatrician given the high risk of developmental delays and/or intellectual disability.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>MPPH syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals with MPPH syndrome have the disorder as the result of a <i>de novo AKT3</i>, <i>CCND2</i>, or <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. In one family, vertical transmission of a <i>PIK3R2</i> pathogenic variant was observed; in two families, parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> for a <i>PIK3R2</i> pathogenic variant seemed likely (given recurrence of MPPH syndrome in sibs and failure to detect the pathogenic variant in DNA <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> from parental blood samples). Each child of an individual with a germline pathogenic variant has a 50% chance of inheriting the pathogenic variant. Once the <i>AKT3</i>, <i>CCND2</i>, or <i>PIK3R2</i> pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk for MPPH syndrome and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="mpph.Diagnosis"><h2 id="_mpph_Diagnosis_">Diagnosis</h2><div id="mpph.Suggestive_Findings"><h3>Suggestive Findings</h3><p>MPPH syndrome <b>should be suspected</b> in individuals with the following clinical and imaging findings [<a class="bk_pop" href="#mpph.REF.mirzaa.2004.353">Mirzaa et al 2004</a>, <a class="bk_pop" href="#mpph.REF.mirzaa.2012.269">Mirzaa et al 2012</a>]. Note: Findings shown in <b>bold</b> are core features.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div><b>Macrocephaly</b>
<b>or</b>
<b>megalencephaly</b> (occipito-frontal circumference &#x02265;2 SD above the mean); onset either prenatally or postnatally</div></li><li class="half_rhythm"><div>Postaxial polydactyly of one or more extremities</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Early-onset epilepsy</div></li><li class="half_rhythm"><div>Intellectual disability</div></li><li class="half_rhythm"><div>Oromotor dysfunction</div></li></ul><p><b>Imaging findings</b></p><ul><li class="half_rhythm"><div><b>Cortical brain malformations, particularly bilateral perisylvian polymicrogyria</b> (BPP)</div></li><li class="half_rhythm"><div>Progressive ventriculomegaly leading to hydrocephalus</div></li><li class="half_rhythm"><div>Cerebellar tonsillar ectopia or Chiari malformations</div></li><li class="half_rhythm"><div>Thick corpus callosum (or mega corpus callosum)</div></li></ul></div><div id="mpph.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><b>The clinical diagnosis</b> of MPPH syndrome <b>can be established</b> in individuals with the two core features: megalencephaly and polymicrogyria).</p><p><b>The molecular diagnosis</b> of MPPH syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with some of the suggestive clinical and imaging features and the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of three genes: <i>AKT3</i>, <i>CCND2</i>, or <i>PIK3R2</i> (<a class="figpopup" href="/books/NBK396098/table/mpph.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figmpphTmoleculargenetictestingusedin" rid-ob="figobmpphTmoleculargenetictestingusedin">Table 1</a>). While most individuals with MPPH syndrome have a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> (i.e., constitutional) pathogenic variant in one of these three genes, some individuals have been reported with a somatic mosaic pathogenic variant in one of these genes (most commonly <i>PIK3R2)</i>.</p><p>Note that failure to detect either a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> or somatic mosaic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of these three genes in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> does not exclude a clinical diagnosis of MPPH syndrome in individuals with the two core clinical and imaging features.</p><p>Molecular genetic testing approaches used to identify <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> and somatic pathogenic variants can include a combination of <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA</b>), and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><div id="mpph.FirstTier_Testing"><h4>First-Tier Testing</h4><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> can be considered in order of the likelihood of identifying a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK396098/table/mpph.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figmpphTmoleculargenetictestingusedin" rid-ob="figobmpphTmoleculargenetictestingusedin">Table 1</a>). Sequence analysis of the gene of interest is performed first.</p></div><div id="mpph.SecondTier_Testing"><h4>Second-Tier Testing</h4><p><b>For <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>.</b> If no <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found in any of the three genes, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> for <i>AKT3</i> or <i>PIK3R2</i> with methods to detect somatic mosaicism may be warranted and/or testing for a large <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of 1q43-q44 that includes <i>AKT3</i>.</p><ul><li class="half_rhythm"><div>Sequence analysis of DNA derived from saliva or skin (whether visibly affected or not) may detect a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> not detected in DNA <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> from blood.</div></li><li class="half_rhythm"><div>Sensitivity to detect low-level <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> of a <a class="def" href="/books/n/gene/glossary/def-item/somatic-pathogenic-variant/">somatic pathogenic variant</a> is theoretically greatest using massively parallel sequencing (also known as <a class="def" href="/books/n/gene/glossary/def-item/next-generation-sequencing/">next-generation sequencing</a>) in tissues other than blood, and in particular will be of high yield when analyzing affected tissues</div></li></ul><p><b>For <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of 1q43-q44 that includes <i>AKT3</i>.</b> Because not all <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/duplication methods are designed to size large CNVs, CMA is the most appropriate for detection of this duplication.</p></div><div id="mpph.Testing_to_Consider"><h4>Testing to Consider</h4><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>AKT3, CCND2</i>, <i>PIK3R2,</i> and other genes of interest (see <a href="#mpph.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered to detect <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> and somatic variants in the MPPH-related genes. Note: (1) The genes included and the <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of multigene panels vary by laboratory and are likely to change over time. (2) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing based tests. (3) Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for variants in the three MPPH-related genes may not be detected by all commercially available multigene panels due primarily to the inability to test tissues other than blood (e.g., skin or buccal cells) and/or technical limitations in detecting low-level mosaicism; thus, clinicians considering use of a multigene panel need to select a panel specifically optimized to detect mosaicism for the three MPPH-related genes.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="mpph.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in MPPH Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK396098/table/mpph.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mpph.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Number of Persons with Molecularly Confirmed MPPH Syndrome Attributed to a Pathogenic Variant in This Gene&#x000a0;<sup>2</sup></th><th id="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Number of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by This Method</th></tr><tr><th headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AKT3</i></td><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12/41</td><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/12</td><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/12&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CCND2</i></td><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12/41</td><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12/12</td><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr><tr><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PIK3R2</i></td><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/41</td><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/17&#x000a0;<sup>7,&#x000a0;8</sup></td><td headers="hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mpph.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mpph.TF.1.1"><p class="no_margin">See <a href="/books/NBK396098/#mpph.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="mpph.TF.1.2"><p class="no_margin">References for the 41 patients with a molecularly confirmed diagnosis: <a class="bk_pop" href="#mpph.REF.mirzaa.2012.269">Mirzaa et al [2012]</a>, <a class="bk_pop" href="#mpph.REF.poduri.2012.41">Poduri et al [2012]</a>, <a class="bk_pop" href="#mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al [2012]</a>, <a class="bk_pop" href="#mpph.REF.wang.2013.2016">Wang et al [2013]</a>, <a class="bk_pop" href="#mpph.REF.chung.2014.1868">Chung et al [2014]</a>, <a class="bk_pop" href="#mpph.REF.jamuar.2014.733">Jamuar et al [2014]</a>, <a class="bk_pop" href="#mpph.REF.mirzaa.2014.510">Mirzaa et al [2014]</a>, <a class="bk_pop" href="#mpph.REF.nakamura.2014.396">Nakamura et al [2014]</a>, <a class="bk_pop" href="#mpph.REF.tapper.2014.e86940">Tapper et al [2014]</a>, <a class="bk_pop" href="#mpph.REF.conti.2015.241">Conti et al [2015]</a>, <a class="bk_pop" href="#mpph.REF.harada.2015.465">Harada et al [2015]</a>, <a class="bk_pop" href="#mpph.REF.nellist.2015.467">Nellist et al [2015]</a>, <a class="bk_pop" href="#mpph.REF.hemming.2016.458">Hemming et al [2016]</a>, <a class="bk_pop" href="#mpph.REF.terrone.2016.1359">Terrone et al [2016]</a>. Note that the other 23 individuals with a clinical diagnosis of MPPH syndrome did not undergo the complete molecular and <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> testing required to detect the range of causative <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> and somatic pathogenic variants.</p></div></dd><dt>3. </dt><dd><div id="mpph.TF.1.3"><p class="no_margin">See <a href="#mpph.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="mpph.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="mpph.TF.1.5"><p class="no_margin">Chromosomal microarray analysis (CMA) using oligonucleotide arrays or SNP arrays. CMA designs in current clinical use target the 1q44 region.</p></div></dd><dt>6. </dt><dd><div id="mpph.TF.1.6"><p class="no_margin">Duplications of 1q43-q44, which include <i>AKT3</i>, are detectable by CMA and cause macrocephaly and intellectual disability [<a class="bk_pop" href="#mpph.REF.chung.2014.1868">Chung et al 2014</a>, <a class="bk_pop" href="#mpph.REF.wang.2013.2016">Wang et al 2013</a>, <a class="bk_pop" href="#mpph.REF.hemming.2016.458">Hemming et al 2016</a>]. Somatic <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of this <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> has been identified in individuals with hemimegalencephaly and focal cortical dysplasia [<a class="bk_pop" href="#mpph.REF.poduri.2012.41">Poduri et al 2012</a>, <a class="bk_pop" href="#mpph.REF.jamuar.2014.733">Jamuar et al 2014</a>, <a class="bk_pop" href="#mpph.REF.conti.2015.241">Conti et al 2015</a>]. Although these large duplications would be detected by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/duplication assays, some methods would be unable to size the duplication.</p></div></dd><dt>7. </dt><dd><div id="mpph.TF.1.7"><p class="no_margin">Mosaicism for a <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been reported in individuals with MPPH syndrome [<a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</a>].</p></div></dd><dt>8. </dt><dd><div id="mpph.TF.1.8"><p class="no_margin">Most individuals with a <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have the same recurrent <a class="figpopup" href="/books/NBK396098/table/mpph.T.pik3r2_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figmpphTpik3r2pathogenicvariantsdiscus" rid-ob="figobmpphTpik3r2pathogenicvariantsdiscus">p.Gly373Arg</a> variant. Only three other <i>PIK3R2</i> pathogenic variants have been reported to date [<a class="bk_pop" href="#mpph.REF.nakamura.2014.396">Nakamura et al 2014</a>, <a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</a>, <a class="bk_pop" href="#mpph.REF.terrone.2016.1359">Terrone et al 2016</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="mpph.Clinical_Characteristics"><h2 id="_mpph_Clinical_Characteristics_">Clinical Characteristics</h2><div id="mpph.Clinical_Description"><h3>Clinical Description</h3><p>The MPPH syndrome is a developmental brain disorder characterized by megalencephaly (brain overgrowth) with the cortical malformation bilateral perisylvian polymicrogyria. Males and females are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> similarly.</p><p>To date 62 individuals with features of MPPH syndrome have been reported with either a clinical diagnosis (presence of the two core clinical and imaging findings: megalencephaly and polymicrogyria) , and/or a molecularly confirmed diagnosis (<a class="figpopup" href="/books/NBK396098/table/mpph.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figmpphTmoleculargenetictestingusedin" rid-ob="figobmpphTmoleculargenetictestingusedin">Table 1</a>) [<a class="bk_pop" href="#mpph.REF.mirzaa.2004.353">Mirzaa et al 2004</a>, <a class="bk_pop" href="#mpph.REF.colombani.2006.466">Colombani et al 2006</a>, <a class="bk_pop" href="#mpph.REF.garavelli.2007.200">Garavelli et al 2007</a>, <a class="bk_pop" href="#mpph.REF.tohyama.2007.148">Tohyama et al 2007</a>, <a class="bk_pop" href="#mpph.REF.pisano.2008.916">Pisano et al 2008</a>, <a class="bk_pop" href="#mpph.REF.tore.2009.1620">Tore et al 2009</a>, <a class="bk_pop" href="#mpph.REF.verkerk.2010.1488">Verkerk et al 2010</a>, <a class="bk_pop" href="#mpph.REF.osterling.2011.370">Osterling et al 2011</a>, <a class="bk_pop" href="#mpph.REF.mirzaa.2012.269">Mirzaa et al 2012</a>, <a class="bk_pop" href="#mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</a>, <a class="bk_pop" href="#mpph.REF.kariminejad.2013.651">Kariminejad et al 2013</a>, <a class="bk_pop" href="#mpph.REF.zamora.2013">Zamora &#x00026; Roberts 2013</a>, <a class="bk_pop" href="#mpph.REF.mirzaa.2014.510">Mirzaa et al 2014</a>, <a class="bk_pop" href="#mpph.REF.nakamura.2014.396">Nakamura et al 2014</a>, <a class="bk_pop" href="#mpph.REF.tapper.2014.e86940">Tapper et al 2014</a>, <a class="bk_pop" href="#mpph.REF.demir.2015.381">Demir et al 2015</a>, <a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</a>, <a class="bk_pop" href="#mpph.REF.nellist.2015.467">Nellist et al 2015</a>, <a class="bk_pop" href="#mpph.REF.terrone.2016.1359">Terrone et al 2016</a>].</p><div id="mpph.Neurologic_Findings"><h4>Neurologic Findings</h4><p><b>Megalencephaly (brain overgrowth).</b> Most individuals with MPPH syndrome reported to date have <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or early postnatal megalencephaly (i.e., rapidly progressive megalencephaly within the first year of life).</p><p>Occipital frontal circumference (OFC) at birth ranges from normal to 6 SD above the mean for age, sex, and gestational age.</p><p>Later OFCs range from 3 to 10 SD above the mean.</p><p>In individuals with MPPH syndrome who develop hydrocephalus, brain overgrowth persists after surgical intervention (e.g., neurosurgical shunting), an observation consistent with true brain overgrowth [<a class="bk_pop" href="#mpph.REF.mirzaa.2012.269">Mirzaa et al 2012</a>].</p><p><b>Cortical malformations.</b> To date, all individuals with MPPH syndrome have cortical brain malformations, particularly polymicrogyria (PMG). In almost all instances, the PMG is bilateral perisylvian polymicrogyria (BPP) and is largely symmetric. BPP is associated with neurologic problems that can include oromotor dysfunction, epilepsy, and intellectual disability.</p><p><b>Ventriculomegaly and hydrocephalus.</b> Variable degrees of ventriculomegaly are seen in almost all children with MPPH syndrome. Nearly 50% of reported individuals with MPPH syndrome have frank hydrocephalus requiring neurosurgical placement of a shunt. Based on limited retrospective data, the risk for hydrocephalus and/or cerebellar tonsillar ectopia with low brain stem or high spinal cord compression appears to be highest in the first two years of life [<a class="bk_pop" href="#mpph.REF.mirzaa.2012.269">Mirzaa et al 2012</a>].</p><p><b>Oromotor dysfunction,</b> including expressive language or speech delay, difficulties handing oral secretions (with profuse drooling), and dysphagia is seen in most individuals with MPPH syndrome. These features are largely attributed to (and well-known to occur with) bilateral perisylvian polymicrogyria [<a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</a>].</p><p><b>Epilepsy.</b> Approximately 50% of individuals with MPPH syndrome have early-onset epilepsy. Epilepsy types range from focal to generalized. Eight children with infantile spasms have been reported. Epilepsy may be refractory to several antiepileptic drugs. One individual with an <i>AKT3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had severe refractory infantile spasms that responded to a ketogenic diet [<a class="bk_pop" href="#mpph.REF.nellist.2015.467">Nellist et al 2015</a>].</p><p><b>Tone abnormalities,</b> particularly hypotonia, are present at birth in most infants. Although tone may improve with age, several older individuals have remained severely hypotonic.</p><p><b>Intellectual disability.</b> Almost all reported individuals with MPPH syndrome have intellectual disability that ranges from mild to severe. The degree of intellectual disability is largely determined by the following:</p><ul><li class="half_rhythm"><div>Extent and severity of the cortical malformations (i.e., severity and distribution of PMG) (see <a href="#mpph.Phenotype_Correlations_by_Gene">Phenotype Correlations by Gene</a>)</div></li><li class="half_rhythm"><div>Age of onset and severity of epilepsy. Early-onset epilepsy (particularly in the newborn period), and generalized epilepsy are typically associated with more severe developmental and cognitive issues.</div></li></ul></div><div id="mpph.Other_Findings"><h4>Other Findings</h4><p><b>Postaxial polydactyly</b> involving from one to all four extremities has been reported in 50% of children with MPPH syndrome.</p><p><b>Additional clinical features</b></p><ul><li class="half_rhythm"><div><b>Common</b></div><ul><li class="half_rhythm"><div>Feeding difficulties (occasionally requiring gastrostomy tube placement)</div></li><li class="half_rhythm"><div>Visual problems (including cortical visual impairment and blindness)</div></li></ul></li><li class="half_rhythm"><div><b>Seen in &#x0003c;5 individuals each</b></div><ul><li class="half_rhythm"><div>Congenital cardiovascular defects (including ventricular septal defect, atrial septal defect)</div></li><li class="half_rhythm"><div>Thyroid problems (including hypothyroidism, Hashimoto thyroiditis)</div></li><li class="half_rhythm"><div>Renal anomalies (e.g., duplicated renal collecting system)</div></li></ul></li><li class="half_rhythm"><div><b>Seen in one individual only</b></div><ul><li class="half_rhythm"><div>Medulloblastoma [<a class="bk_pop" href="#mpph.REF.osterling.2011.370">Osterling et al 2011</a>]</div></li><li class="half_rhythm"><div>Encephalocele, cleft palate, and multiple polyps of the tongue [<a class="bk_pop" href="#mpph.REF.demir.2015.381">Demir et al 2015</a>]</div></li></ul></li></ul></div></div><div id="mpph.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p><b><i>AKT3.</i></b> Features including connective tissue laxity and cutaneous capillary malformations can overlap with the megalencephaly-capillary malformation (MCAP) syndrome (see <a href="#mpph.Differential_Diagnosis">Differential Diagnosis</a>) [<a class="bk_pop" href="#mpph.REF.mirzaa.2012.269">Mirzaa et al 2012</a>, <a class="bk_pop" href="#mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</a>, <a class="bk_pop" href="#mpph.REF.nakamura.2014.396">Nakamura et al 2014</a>, <a class="bk_pop" href="#mpph.REF.nellist.2015.467">Nellist et al 2015</a>].</p><p><b><i>CCND2</i>.</b> Polymicrogyria (PMG) appears to be more severe and widespread, typically extending to the frontal and/or occipital lobes. These extensive cortical malformations correlate with increased severity of epilepsy and intellectual disability [<a class="bk_pop" href="#mpph.REF.mirzaa.2014.510">Mirzaa et al 2014</a>].</p><p>Postaxial polydactyly is more commonly observed than with mutation of either <i>PIK3R2</i> or <i>AKT3</i> [<a class="bk_pop" href="#mpph.REF.mirzaa.2014.510">Mirzaa et al 2014</a>].</p></div><div id="mpph.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>In general no differences in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have been observed between individuals with a molecularly confirmed diagnosis and those with a clinical diagnosis only. The exceptions are several individuals with a molecularly confirmed diagnosis of MPPH syndrome who had bilateral perisylvian polymicrogyria but lacked the core clinical feature of megalencephaly [<a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</a>].</p></div><div id="mpph.Penetrance"><h3>Penetrance</h3><p>Although <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for MPPH syndrome is expected to be high, to date it cannot be definitively determined to be 100% due to the identification of low-level mosaic somatic <i>PIK3R2</i> pathogenic variants in individuals who have only one of the core features (i.e., bilateral perisylvian polymicrogyria) [<a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</a>].</p></div><div id="mpph.Prevalence"><h3>Prevalence</h3><p>MPPH syndrome has been reported to date in 62 individuals from various ethnic backgrounds. Therefore, data regarding prevalence are limited.</p></div></div><div id="mpph.Genetically_Related_Allelic_Disorde"><h2 id="_mpph_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p><a class="figpopup" href="/books/NBK396098/table/mpph.T.allelic_disorders/?report=objectonly" target="object" rid-figpopup="figmpphTallelicdisorders" rid-ob="figobmpphTallelicdisorders">Table 2</a> includes other phenotypes caused by pathogenic variants in the genes associated with MPPH syndrome. Of note, the phenotypic spectrum associated with variants in the three MPPH-related genes will likely continue to expand, at least in part due to the phenotypic variability observed with <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>.</p><div id="mpph.T.allelic_disorders" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Allelic Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK396098/table/mpph.T.allelic_disorders/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mpph.T.allelic_disorders_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mpph.T.allelic_disorders_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_mpph.T.allelic_disorders_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th></tr></thead><tbody><tr><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>AKT3</i></td><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_1" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Gain-of-function variants</td><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hemimegalencephaly (HMEG)&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Focal cortical dysplasia (FCD)</td></tr><tr><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Megalencephaly (MEG)</td></tr><tr><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Loss-of-function variants&#x000a0;<sup>2</sup></td><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Microcephaly and intellectual disability&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>CCND2</i></td><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td></tr><tr><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>PIK3R2</i></td><td headers="hd_h_mpph.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bilateral perisylvian polymicrogyria (BPP)&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mpph.TF.2.1"><p class="no_margin">Two individuals with hemimegalencephaly with the same mosaic <i>AKT3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (p.Glu17Lys; detectable in brain tissue only) have been reported. The paralogous <i>AKT1</i> pathogenic variant (the equivalent change in a related <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>) is associated with <a href="/books/n/gene/proteus/">Proteus syndrome</a> [<a class="bk_pop" href="#mpph.REF.lindhurst.2011.611">Lindhurst et al 2011</a>].</p></div></dd><dt>2. </dt><dd><div id="mpph.TF.2.2"><p class="no_margin">Deletions resulting in presumed loss of function</p></div></dd><dt>3. </dt><dd><div id="mpph.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#mpph.REF.ballif.2012.145">Ballif et al [2012]</a>, <a class="bk_pop" href="#mpph.REF.nagamani.2012.176">Nagamani et al [2012]</a>, <a class="bk_pop" href="#mpph.REF.gai.2015.174">Gai et al [2015]</a></p></div></dd><dt>4. </dt><dd><div id="mpph.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al [2015]</a></p></div></dd></dl></div></div></div></div><div id="mpph.Differential_Diagnosis"><h2 id="_mpph_Differential_Diagnosis_">Differential Diagnosis</h2><div id="mpph.T.disorders_to_consider_in_the_diff" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of MPPH Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK396098/table/mpph.T.disorders_to_consider_in_the_diff/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mpph.T.disorders_to_consider_in_the_diff_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of the Disorder</th></tr><tr><th headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Also in MPPH syndrome</th><th headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not in MPPH syndrome</th></tr></thead><tbody><tr><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MCAP syndrome (see <a href="/books/n/gene/pik3ca-overgrowth/"><i>PIK3CA</i>-Related Segmental Overgrowth</a>)</td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PIK3CA</i></td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>De novo</i> / mosaic&#x000a0;<sup>1</sup></td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>MEG (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or postnatal)</div></li><li class="half_rhythm"><div>BPP</div></li><li class="half_rhythm"><div>Postaxial polydactyly</div></li><li class="half_rhythm"><div>Ventriculomegaly or hydrocephalus</div></li></ul>
</td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Somatic vascular malformations (capillary malformations, often multiple)</div></li><li class="half_rhythm"><div>Somatic overgrowth (focal segmental)</div></li></ul>
</td></tr><tr><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/phts/"><i>PTEN </i>hamartoma tumor syndrome</a></td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PTEN</i></td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>De novo</i> / AD</td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>MEG (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or postnatal)</div></li><li class="half_rhythm"><div>Focal segmental cortical malformations (rare)</div></li></ul>
</td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Papillomatous papules</div></li><li class="half_rhythm"><div>Trichilemmomas</div></li><li class="half_rhythm"><div>Vascular malformations (hemangiomas, arteriovenous malformations)</div></li><li class="half_rhythm"><div>Increased cancer predisposition (thyroid, breast, endometrium)</div></li></ul>
</td></tr><tr><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MTOR</i>-related disorders&#x000a0;<sup>2</sup></td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MTOR</i></td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>De novo</i> / mosaic</td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>MEG (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or postnatal)</div></li></ul>
</td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>FCD</div></li><li class="half_rhythm"><div>Pigmentary <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a>&#x000a0;<sup>2</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>STRADA</i>-related disorders (OMIM <a href="http://omim.org/entry/611087" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">611087</a>)</td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>STRADA</i> (<i>LYK5</i>)</td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>MEG (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or postnatal)</div></li><li class="half_rhythm"><div>Early-onset epilepsy</div></li></ul>
</td><td headers="hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_mpph.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Early lethality</div></li><li class="half_rhythm"><div>Uniformly poor neurodevelopmental outcome</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; BPP = bilateral perisylvian polymicrogyria; FCD = focal cortical dysplasia; MCAP = megalencephaly-capillary malformation; MEG = megalencephaly; MOI = mode(s) of inheritance</p></div></dd><dt>1. </dt><dd><div id="mpph.TF.3.1"><p class="no_margin">MCAP is not typically inherited; to date most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (21/24) had <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for a <i>PIK3CA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, suggesting that the variant occurred post-fertilization in one cell of the multicellular embryo.</p></div></dd><dt>2. </dt><dd><div id="mpph.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#mpph.REF.mirzaa.2016.836">Mirzaa et al [2016]</a></p></div></dd></dl></div></div></div></div><div id="mpph.Management"><h2 id="_mpph_Management_">Management</h2><div id="mpph.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with megalencephaly-postaxial polydactyly-polymicrogyria-hydrocephalus (MPPH) syndrome, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Physical examination with particular attention to head size (OFC)</div></li><li class="half_rhythm"><div>In the presence of hydrocephalus and/or cerebellar tonsillar ectopia, full spinal MRI to evaluate for syringomyelia or syrinx formation</div></li><li class="half_rhythm"><div>Assessment by a pediatric neurologist with evaluation of suspected seizures as indicated</div></li><li class="half_rhythm"><div>Assessment of feeding by a feeding specialist, nutritionist, and gastroenterologist for evidence of chewing and swallowing difficulties and dysphagia</div></li><li class="half_rhythm"><div>Developmental assessment</div></li><li class="half_rhythm"><div>Echocardiogram (to evaluate for structural cardiac defects)</div></li><li class="half_rhythm"><div>Renal ultrasound examination (to evaluate for structural renal defects)</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="mpph.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Neurosurgical complications (hydrocephalus and cerebellar tonsillar ectopia).</b> Findings warranting neurosurgical referral include rapidly enlarging OFC, obstructive hydrocephalus, symptoms of increased intracranial pressure, and progressive or symptomatic cerebellar tonsillar ectopia (CBTE) or Chiari malformation. Early treatment of hydrocephalus may reduce the risk for progressive CBTE, but data to determine the most appropriate neurosurgical management are lacking.</p><p><b>Feeding difficulties such as</b> chewing and swallowing difficulties and dysphagia require evaluation by a feeding specialist and/or gastroenterologist to promote early identification and prompt intervention which may include dietary modification and/or placement of a gastrostomy (G) tube.</p><p>Speech therapy is indicated for difficulties with speech, swallowing, and feeding.</p><p><b>Epilepsy</b> may require long-term antiepileptic treatment.</p><p><b>Developmental delays.</b> Initiation of physical, occupational, and speech therapy is recommended within the first year of life.</p></div><div id="mpph.Surveillance"><h3>Surveillance</h3><p>Given the limited number of individuals reported with MPPH syndrome, no formal surveillance guidelines exist; however, recommended surveillance includes the following:</p><ul><li class="half_rhythm"><div>Follow-up with a pediatric neurologist, at least every six months until age six years, and annually thereafter.</div></li><li class="half_rhythm"><div>Brain MRI to detect hydrocephalus and/or cerebellar tonsillar ectopia; provisionally recommended every six months from birth to age two years, and annually from age two to six years. In older individuals, the frequency should be based on prior results and clinical findings, with particular attention to apnea or other abnormal patterns of respiration, headaches, changes in gait, or other neurologic problems.</div></li><li class="half_rhythm"><div>Long-term neurologic follow up is recommended for management of epilepsy.</div></li><li class="half_rhythm"><div>Routine follow up with a developmental pediatrician is appropriate, given the high risk for developmental delays and/or intellectual disability.</div></li></ul></div><div id="mpph.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#mpph.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="mpph.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="mpph.Genetic_Counseling"><h2 id="_mpph_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="mpph.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>MPPH syndrome is expressed in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="mpph.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">Ninety-nine percent of individuals with MPPH syndrome have the disorder as the result of a <i>de novo AKT3</i>, <i>CCND2</i>, or <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div class="half_rhythm">Vertical transmission of a <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been reported in one family to date (a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent and several children were <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>) [<a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> was suggested in two families by recurrence of MMPH syndrome in sibs and failure to detect the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in DNA <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> from parental blood samples [<a class="bk_pop" href="#mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</a>, <a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the pathogenic variant identified in the proband and a baseline neurologic assessment including measurement of head size.</div></li><li class="half_rhythm"><div class="half_rhythm">If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not detected in leukocyte DNA of either parent, the proband most likely has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant.</div><div class="half_rhythm">Another possible explanation is <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Parental germline mosaicism was suggested in two families by recurrence of a <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in sibs whose parents did not have the variant in blood DNA [<a class="bk_pop" href="#mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</a>, <a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</a>].</div></li></ul><p>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have somatic (and <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>) <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%. While there may be phenotypic variability within the same family, all sibs who inherit a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will have features of MPPH syndrome.</div></li><li class="half_rhythm"><div>If the <i>AKT3</i>, <i>CCND2</i>, or <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (but as-yet unknown) because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>; further data are necessary to establish the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> for sibs.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>AKT3</i>, <i>CCND2</i>, or <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has a 50% chance of inheriting the pathogenic variant; while there may be phenotypic variability within the same family, all offspring who inherit a pathogenic variant will have features of MPPH syndrome.</div></li><li class="half_rhythm"><div>The risk for transmission to offspring of an individual with <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for an MPPH-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (i.e., the pathogenic variant is thought to have occurred post-fertilization in one cell of the multicellular embryo) is expected to be less than 50%.</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>AKT3</i>, <i>CCND2</i>, or <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="mpph.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i> (or, in rare cases, a parent may have <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>). However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to parents of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="mpph.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>AKT3, CCND2,</i> or <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for MPPH syndrome are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="mpph.Resources"><h2 id="_mpph_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><p>No specific resources for MPPH Syndrome have been identified by <i>GeneReviews</i> staff.</p></div><div id="mpph.Molecular_Genetics"><h2 id="_mpph_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="mpph.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>MPPH Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK396098/table/mpph.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mpph.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_mpph.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_mpph.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_mpph.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_mpph.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_mpph.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_mpph.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AKT3</i></a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q43-q44</a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y243" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RAC-gamma serine/threonine-protein kinase</a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AKT3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AKT3</a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AKT3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AKT3</a></td></tr><tr><td headers="hd_b_mpph.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/894" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CCND2</i></a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=894" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12p13<wbr style="display:inline-block"></wbr>​.32</a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P30279" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">G1/S-specific cyclin-D2</a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CCND2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCND2</a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CCND2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCND2</a></td></tr><tr><td headers="hd_b_mpph.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5296" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PIK3R2</i></a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5296" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19p13<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O00459" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Phosphatidylinositol 3-kinase regulatory subunit beta</a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PIK3R2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PIK3R2</a></td><td headers="hd_b_mpph.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PIK3R2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PIK3R2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="mpph.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="mpph.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for MPPH Syndrome (<a href="/omim/123833,603157,603387,611223,615937,615938" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK396098/table/mpph.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mpph.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/123833" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">123833</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CYCLIN D2; CCND2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603157" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603157</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 2; PIK3R2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603387" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603387</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611223" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611223</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AKT SERINE/THREONINE KINASE 3; AKT3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615937" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615937</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2; MPPH2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615938" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615938</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3</td></tr></tbody></table></div></div><div id="mpph.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p><i>AKT3</i>, <i>CCND2</i>, and <i>PIK3R2</i> encode key proteins within the phosphatidylinositol-4,5-bisphosphate-3-kinase (PI3K)-protein kinase B (AKT)-mammalian target of rapamycin (mTOR) pathway, a major signaling pathway involved with key cellular functions including protein synthesis, metabolism, cell cycle, survival, growth, and proliferation [<a class="bk_pop" href="#mpph.REF.engelman.2006.606">Engelman et al 2006</a>, <a class="bk_pop" href="#mpph.REF.vanhaesebroeck.2012.195">Vanhaesebroeck et al 2012</a>].</p><p>Gain-of-function variants in these and other genes within the pathway (including <i>PIK3CA</i> and <i>MTOR</i>) are associated with a spectrum of diffuse and segmental developmental brain disorders including megalencephaly, hemimegalencephaly, polymicrogyria, and focal cortical dysplasia [<a class="bk_pop" href="#mpph.REF.mirzaa.2014.156">Mirzaa &#x00026; Poduri 2014</a>].</p><p>AKT3 is a serine/threonine kinase and the principal target of phosphatidylinositol 3,4,5-trisphosphate (PIP3). <i>PIK3R2</i> encodes the beta regulatory subunit of the PI3K enzymatic complex, a kinase complex that phosphorylates phosphatidylinositol 4,5-bisphosphate, to generate PIP3. Binding of PIP3 to the AKT complex leads to phosphorylation of multiple downstream PI3K-AKT-MTOR targets, including MTOR (mammalian target of rapamycin) itself.</p><p>CCND2, a protein that mediates the G1-S transition of the cell cycle, is among the downstream targets of the PI3K-AKT-MTOR pathway [<a class="bk_pop" href="#mpph.REF.engelman.2006.606">Engelman et al 2006</a>, <a class="bk_pop" href="#mpph.REF.mirzaa.2014.510">Mirzaa et al 2014</a>].</p><div id="mpph.AKT3"><h4><i>AKT3</i></h4><p><b>Gene structure.</b> The V-Akt murine thymoma viral oncogene homolog 3 encodes the serine/threonine kinase, AKT3. <i>AKT3</i> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005465.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005465.4</a>) comprises 13 coding exons.</p><p><b>Pathogenic variants.</b> To date, three <i>AKT3</i> <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been reported (see <a class="figpopup" href="/books/NBK396098/table/mpph.T.akt3_variants_discussed_in_this_g/?report=objectonly" target="object" rid-figpopup="figmpphTakt3variantsdiscussedinthisg" rid-ob="figobmpphTakt3variantsdiscussedinthisg">Table 4</a>) [<a class="bk_pop" href="#mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</a>, <a class="bk_pop" href="#mpph.REF.nakamura.2014.396">Nakamura et al 2014</a>, <a class="bk_pop" href="#mpph.REF.nellist.2015.467">Nellist et al 2015</a>]. Data suggest that the mutational spectrum is broader [unpublished data].</p><div id="mpph.T.akt3_variants_discussed_in_this_g" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>AKT3</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK396098/table/mpph.T.akt3_variants_discussed_in_this_g/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mpph.T.akt3_variants_discussed_in_this_g_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.548T&#x0003e;A</td><td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val183Asp</td><td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005465.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005465<wbr style="display:inline-block"></wbr>​.4</a></td></tr><tr><td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.686A&#x0003e;G</td><td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn229Ser</td></tr><tr><td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1393C&#x0003e;T</td><td headers="hd_h_mpph.T.akt3_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg465Trp</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>AKT3</i> encodes 479 amino acids of the v-AKT murine thymoma viral oncogene homolog 3 or RAC-gamma serine/threonine protein kinase. AKT3 is a key regulator of PI3K-AKT-MTOR pathway function including metabolism, proliferation, cell survival, growth, and angiogenesis. AKT3 is highly expressed in brain lung and kidney. It is composed of three functional domains (PH, kinase and C-terminal domains).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Gain-of-function pathogenic variants in <i>AKT3</i> lead to higher levels of phosphorylation of PI3K-AKT-MTOR pathway target proteins [<a class="bk_pop" href="#mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</a>]. Further, in a study of malformations associated with focal cortical epilepsy caused by the p.Glu17Lys <i>AKT3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, p.Glu17Lys expressing neural progenitors caused a non-cell autonomous migration defect in neighboring cells. Treatments aimed at either blocking downstream AKT signaling or <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> AKT targets restored migration, suggesting that PI3K-AKT-MTOR pathway inhibitors may be potential treatments for some forms of focal epilepsy [<a class="bk_pop" href="#mpph.REF.baek.2015.1445">Baek et al 2015</a>].</p><p><b>Cancer and benign tumors.</b> AKT3 is a key modulator of several <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> tumors (including melanoma, glioma, and ovarian cancer) that occur in the absence of any other findings of MPPH syndrome. Somatic <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants across all functional domains of <i>AKT3</i> are seen in a variety of tumors in the Catalogue of Somatic Mutations in Cancer (<a href="http://cancer.sanger.ac.uk/cosmic/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COSMIC</a>). These somatic variants in <i>AKT3</i> are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; thus, predisposition to these tumors is not heritable.</p></div><div id="mpph.CCND2"><h4><i>CCND2</i></h4><p><b>Gene structure.</b>
<i>CCND2</i> encodes the cyclin D2 protein that regulates the G1-S transition of the cell cycle. <i>CCND2</i> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001759.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001759.3</a>) comprises five coding exons.</p><p><b>Pathogenic variants.</b> To date, seven <i>CCND2</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants involving four amino acid residues have been reported. All are within <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5, the terminal exon of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p><div id="mpph.T.ccnd2_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>CCND2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK396098/table/mpph.T.ccnd2_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mpph.T.ccnd2_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.808A&#x0003e;T</td><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys270Ter</td><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001759.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001759<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.838A&#x0003e;G</td><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr280Ala</td></tr><tr><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.839C&#x0003e;A</td><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr280Asn</td></tr><tr><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.842C&#x0003e;G</td><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro281Arg</td></tr><tr><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.842C&#x0003e;T</td><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro281Leu</td></tr><tr><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.841C&#x0003e;T</td><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro281Ser</td></tr><tr><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.851T&#x0003e;G</td><td headers="hd_h_mpph.T.ccnd2_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val284Gly</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>CCND2</i> encodes 289 amino acids of the cyclin D2 protein, which is a regulatory component of the cyclin D2-CDK4 (DC) complex. This complex phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G1-S transition.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>CCND2</i> pathogenic variants cause accumulation of degradation-resistant CCND2. Specifically, the amino acid residue p.Thr280 has been shown to be the site for GSK-3&#x003b2; mediated phosphorylation, which triggers ubiquitin-mediated degradation of CCND2. Therefore, pathogenic variants abolishing this phosphorylation site result in accumulation of degradation-resistant cyclin D2, cell cycle progression, and increased neuronal proliferation [<a class="bk_pop" href="#mpph.REF.mirzaa.2014.510">Mirzaa et al 2014</a>].</p><p><b>Cancer and benign tumors.</b> Sporadic tumors (including ovarian and testicular tumors) occurring in the absence of any other findings of MPPH syndrome have shown high level expression of <i>CCND2</i>. These somatic variants are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; thus, predisposition to these tumors is not heritable. CCND2 is also overexpressed in astrocytomas and glioblastomas [<a class="bk_pop" href="#mpph.REF.parry.2012">Parry &#x00026; Engh 2012</a>, <a class="bk_pop" href="#mpph.REF.koyamanasu.2013.3840">Koyama-Nasu et al 2013</a>].</p></div><div id="mpph.PIK3R2"><h4><i>PIK3R2</i></h4><p><b>Gene structure.</b> The phosphatidylinositol 3-kinase &#x003b2; regulatory subunit (PIK3R2) encodes a lipid kinase within the PI3K enzymatic complex. <i>PIK3R2</i> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005027.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005027.2</a>) comprises 15 coding exons.</p><p><b>Pathogenic variants.</b> To date, 33 of the 35 published incidences of <i>PIK3R2</i> pathogenic variants are a single recurrent variant (p.Gly373Arg) within the first sequence homology (SH) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the protein [<a class="bk_pop" href="#mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</a>, <a class="bk_pop" href="#mpph.REF.nakamura.2014.396">Nakamura et al 2014</a>, <a class="bk_pop" href="#mpph.REF.mirzaa.2015.1182">Mirzaa et al 2015</a>, <a class="bk_pop" href="#mpph.REF.terrone.2016.1359">Terrone et al 2016</a>].</p><div id="mpph.T.pik3r2_pathogenic_variants_discus" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p><i>PIK3R2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK396098/table/mpph.T.pik3r2_pathogenic_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mpph.T.pik3r2_pathogenic_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1117G&#x0003e;A</td><td headers="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly373Arg</td><td headers="hd_h_mpph.T.pik3r2_pathogenic_variants_discus_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005027.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005027<wbr style="display:inline-block"></wbr>​.2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>PIK3R2</i> encodes the regulatory subunit of the PI3K enzymatic complex, a kinase that phosphorylates PtdIns (4,5) P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 recruits PH <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-containing proteins to the membrane, including AKT and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility, and morphology [<a class="bk_pop" href="#mpph.REF.engelman.2006.606">Engelman et al 2006</a>]. PIK3R2 binds to activated (phosphorylated) protein-tyrosine kinases through its SH2 domain and acts as an adapter, mediating the association of the p110 catalytic unit with the plasma membrane.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The recurrent <i>PIK3R2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, p.Gly373Arg, causes hyperactivation of PI3K-AKT-MTOR pathway downstream targets [<a class="bk_pop" href="#mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</a>].</p><p><b>Cancer and benign tumors.</b> Somatic <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> pathogenic variants in <i>PIK3R2</i> occur in <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> tumors, particularly endometrial cancer in the absence of any other findings of MPPH syndrome. These somatic <i>PIK3R2</i> variants are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; thus, predisposition to these tumors is not heritable.</p></div></div></div><div id="mpph.References"><h2 id="_mpph_References_">References</h2><div id="mpph.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.baek.2015.1445">Baek ST, Copeland B, Yun EJ, Kwon SK, Guemez-Gamboa A, Schaffer AE, Kim S, Kang HC, Song S, Mathern GW, Gleeson JG. An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development. <span><span class="ref-journal">Nat Med. </span>2015;<span class="ref-vol">21</span>:1445–54.</span> [<a href="/pmc/articles/PMC4955611/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4955611</span></a>] [<a href="/pubmed/26523971" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26523971</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.ballif.2012.145">Ballif BC, Rosenfeld JA, Traylor R, Theisen A, Bader PI, Ladda RL, Sell SL, Steinraths M, Surti U, McGuire M, Williams S, Farrell SA, Filiano J, Schnur RE, Coffey LB, Tervo RC, Stroud T, Marble M, Netzloff M, Hanson K, Aylsworth AS, Bamforth JS, Babu D, Niyazov DM, Ravnan JB, Schultz RA, Lamb AN, Torchia BS, Bejjani BA, Shaffer LG. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44. <span><span class="ref-journal">Hum Genet. </span>2012;<span class="ref-vol">131</span>:145–56.</span> [<a href="/pubmed/21800092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21800092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.chung.2014.1868">Chung BK, Eydoux P, Van Karnebeek CD, Gibson WT. Duplication of AKT3 is associated with macrocephaly and speech delay. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:1868–9.</span> [<a href="/pubmed/24700746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24700746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.colombani.2006.466">Colombani M, Chouchane M, Pitelet G, Morales L, Callier P, Pinard JP, Lion-Fran&#x000e7;ois L, Thauvin-Robinet C, Mugneret F, Huet F, Guibaud L, Faivre L. A new case of megalencephaly and perisylvian polymicrogyria with post-axial polydactyly and hydrocephalus: MPPH syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2006;<span class="ref-vol">49</span>:466–71.</span> [<a href="/pubmed/16807158" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16807158</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.conti.2015.241">Conti V, Pantaleo M, Barba C, Baroni G, Mei D, Buccoliero AM, Giglio S, Giordano F, Baek ST, Gleeson JG, Guerrini R. Focal dysplasia of the cerebral cortex and infantile spasms associated with somatic 1q21.1-q44 duplication including the AKT3 gene. <span><span class="ref-journal">Clin Genet. </span>2015;<span class="ref-vol">88</span>:241–7.</span> [<a href="/pubmed/25091978" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25091978</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.demir.2015.381">Demir N, Peker E, G&#x000fc;l&#x0015f;en I, Kaba S, Tuncer O. Megalencephaly, polymicrogyria, polydactyly and hydrocephalus (mpph) syndrome: a new case with occipital encephalocele and cleft palate. <span><span class="ref-journal">Genet Couns. </span>2015;<span class="ref-vol">26</span>:381–5.</span> [<a href="/pubmed/26852507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26852507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.engelman.2006.606">Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. <span><span class="ref-journal">Nat Rev Genet. </span>2006;<span class="ref-vol">7</span>:606–19.</span> [<a href="/pubmed/16847462" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16847462</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.gai.2015.174">Gai D, Haan E, Scholar M, Nicholl J, Yu S. Phenotypes of AKT3 deletion: a case report and literature review. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:174–9.</span> [<a href="/pubmed/25424989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25424989</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.garavelli.2007.200">Garavelli L, Guareschi E, Errico S, Simoni A, Bergonzini P, Zollino M, Gurrieri F, Mancini GM, Schot R, Van Der Spek PJ, Frigieri G, Zonari P, Albertini E, Giustina ED, Amarri S, Banchini G, Dobyns WB, Neri G. Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus (MPPH): report of a new case. <span><span class="ref-journal">Neuropediatrics. </span>2007;<span class="ref-vol">38</span>:200–3.</span> [<a href="/pubmed/18058629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18058629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.harada.2015.465">Harada A, Miya F, Utsunomiya H, Kato M, Yamanaka T, Tsunoda T, Kosaki K, Kanemura Y, Yamasaki M. Sudden death in a case of megalencephaly capillary malformation associated with a de novo mutation in AKT3. <span><span class="ref-journal">Childs Nerv Syst. </span>2015;<span class="ref-vol">31</span>:465–71.</span> [<a href="/pubmed/25416470" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25416470</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.hemming.2016.458">Hemming IA, Forrest AR, Shipman P, Woodward KJ, Walsh P, Ravine DG, Heng JI. Reinforcing the association between distal 1q CNVs and structural brain disorder: A case of a complex 1q43-q44 CNV and a review of the literature. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2016;<span class="ref-vol">171B</span>:458–67.</span> [<a href="/pubmed/26853090" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26853090</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.jamuar.2014.733">Jamuar SS, Lam AT, Kircher M, D'Gama AM, Wang J, Barry BJ, Zhang X, Hill RS, Partlow JN, Rozzo A, Servattalab S, Mehta BK, Topcu M, Amrom D, Andermann E, Dan B, Parrini E, Guerrini R, Scheffer IE, Berkovic SF, Leventer RJ, Shen Y, Wu BL, Barkovich AJ, Sahin M, Chang BS, Bamshad M, Nickerson DA, Shendure J, Poduri A, Yu TW, Walsh CA. Somatic mutations in cerebral cortical malformations. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">371</span>:733–43.</span> [<a href="/pmc/articles/PMC4274952/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4274952</span></a>] [<a href="/pubmed/25140959" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25140959</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.kariminejad.2013.651">Kariminejad A, Radmanesh F, Rezayi AR, Tonekaboni SH, Gleeson JG. Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome: a case report. <span><span class="ref-journal">J Child Neurol. </span>2013;<span class="ref-vol">28</span>:651–7.</span> [<a href="/pubmed/22859694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22859694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.koyamanasu.2013.3840">Koyama-Nasu R, Nasu-Nishimura Y, Todo T, Ino Y, Saito N, Aburatani H, Funato K, Echizen K, Sugano H, Haruta R, Matsui M, Takahashi R, Manabe E, Oda T, Akiyama T. The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells. <span><span class="ref-journal">Oncogene. </span>2013;<span class="ref-vol">32</span>:3840–5.</span> [<a href="/pubmed/22964630" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22964630</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.lindhurst.2011.611">Lindhurst MJ, Sapp JC, Teer JK, Johnston JJ, Finn EM, Peters K, Turner J, Cannons JL, Bick D, Blakemore L, Blumhorst C, Brockmann K, Calder P, Cherman N, Deardorff MA, Everman DB, Golas G, Greenstein RM, Kato BM, Keppler-Noreuil KM, Kuznetsov SA, Miyamoto RT, Newman K, Ng D, O'Brien K, Rothenberg S, Schwartzentruber DJ, Singhal V, Tirabosco R, Upton J, Wientroub S, Zackai EH, Hoag K, Whitewood-Neal T, Robey PG, Schwartzberg PL, Darling TN, Tosi LL, Mullikin JC, Biesecker LG. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. <span><span class="ref-journal">N Engl J Med. </span>2011;<span class="ref-vol">365</span>:611–9.</span> [<a href="/pmc/articles/PMC3170413/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3170413</span></a>] [<a href="/pubmed/21793738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21793738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.mirzaa.2004.353">Mirzaa G, Dodge NN, Glass I, Day C, Gripp K, Nicholson L, Straub V, Voit T, Dobyns WB. Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus: a rare brain malformation syndrome associated with mental retardation and seizures. <span><span class="ref-journal">Neuropediatrics. </span>2004;<span class="ref-vol">35</span>:353–9.</span> [<a href="/pubmed/15627943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15627943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.mirzaa.2016.836">Mirzaa GM, Campbell CD, Solovieff N, Goold CP, Jansen LA, Menon S, Timms AE, Conti V, Biag JD, Olds C, Boyle EA, Collins S, Ishak G, Poliachik SL, Girisha KM, Yeung KS, Chung BH, Rahikkala E, Gunter SA, McDaniel SS, Macmurdo CF, Bernstein JA, Martin B, Leary RJ, Mahan S, Liu S, Weaver M, Dorschner MO, Jhangiani S, Muzny DM, Boerwinkle E, Gibbs RA, Lupski JR, Shendure J, Saneto RP, Novotny EJ, Wilson CJ, Sellers WR, Morrissey MP, Hevner RF, Ojemann JG, Guerrini R, Murphy LO, Winckler W, Dobyns WB. Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. <span><span class="ref-journal">JAMA Neurol. </span>2016;<span class="ref-vol">73</span>:836–45.</span> [<a href="/pmc/articles/PMC4979321/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4979321</span></a>] [<a href="/pubmed/27159400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27159400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.mirzaa.2015.1182">Mirzaa GM, Conti V, Timms AE, Smyser CD, Ahmed S, Carter M, Barnett S, Hufnagel RB, Goldstein A, Narumi-Kishimoto Y, Olds C, Collins S, Johnston K, Deleuze JF, Nitschk&#x000e9; P, Friend K, Harris C, Goetsch A, Martin B, Boyle EA, Parrini E, Mei D, Tattini L, Slavotinek A, Blair E, Barnett C, Shendure J, Chelly J, Dobyns WB, Guerrini R. Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study. <span><span class="ref-journal">Lancet Neurol. </span>2015;<span class="ref-vol">14</span>:1182–95.</span> [<a href="/pmc/articles/PMC4672724/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4672724</span></a>] [<a href="/pubmed/26520804" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26520804</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.mirzaa.2012.269">Mirzaa GM, Conway RL, Gripp KW, Lerman-Sagie T, Siegel DH, deVries LS, Lev D, Kramer N, Hopkins E, Graham JM Jr, Dobyns WB. Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:269–91.</span> [<a href="/pubmed/22228622" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22228622</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.mirzaa.2014.510">Mirzaa GM, Parry DA, Fry AE, Giamanco KA, Schwartzentruber J, Vanstone M, Logan CV, Roberts N, Johnson CA, Singh S, Kholmanskikh SS, Adams C, Hodge RD, Hevner RF, Bonthron DT, Braun KP, Faivre L, Rivi&#x000e8;re JB, St-Onge J, Gripp KW, Mancini GM, Pang K, Sweeney E, van Esch H, Verbeek N, Wieczorek D, Steinraths M, Majewski J, Boycott KM, Pilz DT, Ross ME, Dobyns WB, Sheridan EG, et al.  De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. <span><span class="ref-journal">Nat Genet. </span>2014;<span class="ref-vol">46</span>:510–5.</span> [<a href="/pmc/articles/PMC4004933/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4004933</span></a>] [<a href="/pubmed/24705253" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24705253</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.mirzaa.2014.156">Mirzaa GM, Poduri A. Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2014;<span class="ref-vol">166C</span>:156–72.</span> [<a href="/pubmed/24888963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24888963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.nagamani.2012.176">Nagamani SC, Erez A, Bay C, Pettigrew A, Lalani SR, Herman K, Graham BH, Nowaczyk MJ, Proud M, Craigen WJ, Hopkins B, Kozel B, Plunkett K, Hixson P, Stankiewicz P, Patel A, Cheung SW. Delineation of a deletion region critical for corpus callosal abnormalities in chromosome 1q43-q44. <span><span class="ref-journal">Eur J Hum Genet. </span>2012;<span class="ref-vol">20</span>:176–9.</span> [<a href="/pmc/articles/PMC3260920/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3260920</span></a>] [<a href="/pubmed/21934713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21934713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.nakamura.2014.396">Nakamura K, Kato M, Tohyama J, Shiohama T, Hayasaka K, Nishiyama K, Kodera H, Nakashima M, Tsurusaki Y, Miyake N, Matsumoto N, Saitsu H. AKT3 and PIK3R2 mutations in two patients with megalencephaly-related syndromes: MCAP and MPPH. <span><span class="ref-journal">Clin Genet. </span>2014;<span class="ref-vol">85</span>:396–8.</span> [<a href="/pubmed/23745724" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23745724</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.nellist.2015.467">Nellist M, Schot R, Hoogeveen-Westerveld M, Neuteboom RF, van der Louw EJ, Lequin MH, Bindels-de Heus K, Sibbles BJ, de Coo R, Brooks A, Mancini GM. Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemia. <span><span class="ref-journal">Mol Genet Metab. </span>2015;<span class="ref-vol">114</span>:467–73.</span> [<a href="/pubmed/25523067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25523067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.osterling.2011.370">Osterling WL, Boyer RS, Hedlund GL, Bale JF. Jr. MPPH syndrome: two new cases. <span><span class="ref-journal">Pediatr Neurol. </span>2011;<span class="ref-vol">44</span>:370–3.</span> [<a href="/pubmed/21481746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21481746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.parry.2012">Parry PV, Engh JA. The role of cyclin-d2 in the tumorigenesis of glioblastoma. Neurosurgery. 2012; 71:N22-3. [<a href="/pubmed/23160398" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23160398</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.pisano.2008.916">Pisano T, Meloni M, Cianchetti C, Falchi M, Nucaro A, Pruna D. Megalencephaly, polymicrogyria, and hydrocephalus (MPPH) syndrome: a new case with syndactyly. <span><span class="ref-journal">J Child Neurol. </span>2008;<span class="ref-vol">23</span>:916–8.</span> [<a href="/pubmed/18474936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18474936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.poduri.2012.41">Poduri A, Evrony GD, Cai X, Elhosary PC, Beroukhim R, Lehtinen MK, Hills LB, Heinzen EL, Hill A, Hill RS, Barry BJ, Bourgeois BF, Riviello JJ, Barkovich AJ, Black PM, Ligon KL, Walsh CA. Somatic activation of AKT3 causes hemispheric developmental brain malformations. <span><span class="ref-journal">Neuron. </span>2012;<span class="ref-vol">74</span>:41–8.</span> [<a href="/pmc/articles/PMC3460551/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3460551</span></a>] [<a href="/pubmed/22500628" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22500628</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.rivi_re.2012.934">Rivi&#x000e8;re JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL, St-Onge J, Schwartzentruber JA, Gripp KW, Nikkel SM, Worthylake T, Sullivan CT, Ward TR, Butler HE, Kramer NA, Albrecht B, Armour CM, Armstrong L, Caluseriu O, Cytrynbaum C, Drolet BA, Innes AM, Lauzon JL, Lin AE, Mancini GM, Meschino WS, Reggin JD, Saggar AK, Lerman-Sagie T, Uyanik G, Weksberg R, Zirn B, Beaulieu CL, et al.  De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:934–40.</span> [<a href="/pmc/articles/PMC3408813/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3408813</span></a>] [<a href="/pubmed/22729224" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22729224</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.tapper.2014.e86940">Tapper WJ, Foulds N, Cross NC, Aranaz P, Score J, Hidalgo-Curtis C, Robinson DO, Gibson J, Ennis S, Temple IK, Collins A. Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations. <span><span class="ref-journal">PloS One. </span>2014;<span class="ref-vol">9</span>:e86940.</span> [<a href="/pmc/articles/PMC3908952/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3908952</span></a>] [<a href="/pubmed/24497998" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24497998</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.terrone.2016.1359">Terrone G, Voisin N, Abdullah Alfaiz A, Cappuccio G, Vitiello G, Guex N, D'Amico A, James Barkovich A, Brunetti-Pierri N, Del Giudice E, Reymond A. De novo PIK3R2 variant causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia. <span><span class="ref-journal">Eur J Hum Genet. </span>2016;<span class="ref-vol">24</span>:1359–62.</span> [<a href="/pmc/articles/PMC4989218/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4989218</span></a>] [<a href="/pubmed/26860062" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26860062</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.tohyama.2007.148">Tohyama J, Akasaka N, Saito N, Yoshimura J, Nishiyama K, Kato M. Megalencephaly and polymicrogyria with polydactyly syndrome. <span><span class="ref-journal">Pediatr Neurol. </span>2007;<span class="ref-vol">37</span>:148–51.</span> [<a href="/pubmed/17675034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17675034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.tore.2009.1620">Tore HG, McKinney AM, Nagar VA, Lohman B, Truwit CL, Raybaud C. Syndrome of megalencephaly, polydactyly, and polymicrogyria lacking frank hydrocephalus, with associated MR imaging findings. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2009;<span class="ref-vol">30</span>:1620–2.</span> [<a href="/pubmed/19369601" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19369601</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.vanhaesebroeck.2012.195">Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signalling: the path to discovery and understanding. <span><span class="ref-journal">Nat Rev Mol Cell Biol. </span>2012;<span class="ref-vol">13</span>:195–203.</span> [<a href="/pubmed/22358332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22358332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.verkerk.2010.1488">Verkerk AJ, Schot R, van Waterschoot L, Douben H, Poddighe PJ, Lequin MH, de Vries LS, Terhal P, Hahnemann JM, de Coo IF, de Wit MC, Wafelman LS, Garavelli L, Dobyns WB, Van der Spek PJ, de Klein A, Mancini GM. Unbalanced der(5)t(5;20) translocation associated with megalencephaly, perisylvian polymicrogyria, polydactyly and hydrocephalus. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:1488–97.</span> [<a href="/pmc/articles/PMC2908594/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2908594</span></a>] [<a href="/pubmed/20503325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20503325</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.wang.2013.2016">Wang D, Zeesman S, Tarnopolsky MA, Nowaczyk MJ. Duplication of AKT3 as a cause of macrocephaly in duplication 1q43q44. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:2016–9.</span> [<a href="/pubmed/23794269" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23794269</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mpph.REF.zamora.2013">Zamora TG, Roberts KD. Four-year follow-up of megalencephaly, polymicrogyria, postaxial polydactyly and hydrocephalus (MPPH) syndrome. BMJ Case Rep. 2013;2013. [<a href="/pmc/articles/PMC3822249/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3822249</span></a>] [<a href="/pubmed/24092603" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24092603</span></a>]</div></li></ul></div></div><div id="mpph.Chapter_Notes"><h2 id="_mpph_Chapter_Notes_">Chapter Notes</h2><div id="mpph.Author_Notes"><h3>Author Notes</h3><p>Dr Ghayda Mirzaa is a physician scientist at the Seattle Children's Research Institute. Her research is focused on understanding the developmental basis and genetic causes of a wide range of developmental brain disorders, with a particular focus on brain growth problems including megalencephaly and microcephaly. Dr Mirzaa's research team studies the natural history of MPPH syndrome.</p></div><div id="mpph.Acknowledgments"><h3>Acknowledgments</h3><p>We thank our patients and their families and health care providers for their collaboration and contribution to our knowledge about MPPH syndrome.</p></div><div id="mpph.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>17 November 2016 (bp) Review posted live</div></li><li class="half_rhythm"><div>31 March 2016 (gm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK396098</span><span class="label">PMID: <a href="/pubmed/27854409" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">27854409</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/merrf/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mpv17-mtdep/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK396098&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK396098/?report=reader">PubReader</a></li><li><a href="/books/NBK396098/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK396098" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK396098" style="display:none" title="Cite this Page"><div class="bk_tt">Mirzaa G. MPPH Syndrome. 2016 Nov 17. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK396098/pdf/Bookshelf_NBK396098.pdf">PDF version of this page</a> (483K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#mpph.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#mpph.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#mpph.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#mpph.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#mpph.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#mpph.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#mpph.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#mpph.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#mpph.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#mpph.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#mpph.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=894[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CCND2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10000[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AKT3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5296[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PIK3R2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4341196" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4341196" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4341196" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4341196" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23946963" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PIK3CA</i>-Related Segmental Overgrowth</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PIK3CA</i>-Related Segmental Overgrowth<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mirzaa G, Conway R, Graham JM Jr, Dobyns WB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26520804" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study.</a><span class="source">[Lancet Neurol. 2015]</span><div class="brieflinkpop offscreen_noflow">Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mirzaa GM, Conti V, Timms AE, Smyser CD, Ahmed S, Carter M, Barnett S, Hufnagel RB, Goldstein A, Narumi-Kishimoto Y, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Lancet Neurol. 2015 Dec; 14(12):1182-95. Epub 2015 Oct 29.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23592320" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.</a><span class="source">[Am J Med Genet C Semin Med Gen...]</span><div class="brieflinkpop offscreen_noflow">Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mirzaa GM, Rivière JB, Dobyns WB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet C Semin Med Genet. 2013 May; 163C(2):122-30. Epub 2013 Apr 16.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24705253" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.</a><span class="source">[Nat Genet. 2014]</span><div class="brieflinkpop offscreen_noflow">De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mirzaa G, Parry DA, Fry AE, Giamanco KA, Schwartzentruber J, Vanstone M, Logan CV, Roberts N, Johnson CA, Singh S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Nat Genet. 2014 May; 46(5):510-515. Epub 2014 Apr 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301680" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Costello Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Costello Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gripp KW, Rauen KA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=27854409" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=27854409" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0418b375f66d18aa88aa8e">MPPH Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">MPPH Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:19:31-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BB837E04144210000000001F200AA&amp;ncbi_session=CE8BB837E0418B21_0498SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK396098%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK396098&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK396098/&amp;ncbi_pagename=MPPH Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BB837E0418B21_0498SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>